Moderna Raises 2026 Revenue Growth Outlook to 15%–25%
Moderna expects 2026 revenue growth of 15% to 25%, up from its original outlook of up to 10%. It also expects approximately 10 percentage points of gross margin expansion, excluding a litigation settlement charge, and approximately $4 billion in 2027 cash costs.
Story updates
12:06:15 PM UTC
SquawkNews
MODERNA: EXPECTS ANNUAL CASH COSTS OF ABOUT $4 BILLION TO $4.5 BILLION FROM 2027 THROUGH 2030
Moderna expects 2026 revenue growth of 15% to 25%, versus its original outlook of up to 10%, and approximately 10 percentage points of gross margin expansion, excluding a litigation settlement charge. It expects approximately $4B in 2027 cash costs and approximately $9B in total liquidity at year-e…